Adverum Biotechnologies (ADVM) PT Lowered to $2 at RBC Capital Following Earnings
Tweet Send to a Friend
(Updated - March 19, 2024 6:50 AM EDT)
RBC Capital analyst Luca Issi lowered the price target on Adverum ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Luca Issi lowered the price target on Adverum ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
